MedTrace Logo

Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty

NCT03849885 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 496

Last updated 2023-01-10

No results posted yet for this study

Summary

This study is being done to investigate the colonization rate(growth rate) of a particular type of low-virulence (does not typically cause infection) bacterium called Propionibacterium, more specifically P acnes, the same bacterium that is responsible for the majority of acne. Information affecting hip surgery is currently unknown.

Conditions

  • Degenerative Osteoarthritis

Interventions

DRUG

Benzoyl peroxide gel

Skin prep with Chlorohexidine wipes and BPO.

Sponsors & Collaborators

  • Colorado Joint Replacement

    lead OTHER

Principal Investigators

  • Jason M Jennings, MD DPT · Colorado Joint Replacement

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-02
Primary Completion
2023-12-31
Completion
2024-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03849885 on ClinicalTrials.gov